Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Fluxion Delivers First Commercial Shipments of IsoFlux™ System

Published: Friday, June 07, 2013
Last Updated: Friday, June 07, 2013
Bookmark and Share
Platform enables pharma, research, and diagnostic companies to utilize blood samples for cancer diagnostic breakthroughs.

Fluxion Biosciences, Inc. has announced that the first round of IsoFlux instruments has been delivered to customers around the world.

Initially announced in November, the IsoFlux System is an automated instrument and microfluidic cartridge for high sensitivity enrichment of rare cells such as circulating tumor cells (CTCs), stem cells, and immune cells.

The first 15 instrument placements included global pharma companies, emerging biotechs, and leading cancer research institutes.

"We're very pleased that after two years of research and development, the IsoFlux System is now in the hands of very capable customers," said Jeff Jensen, CEO of Fluxion.

Jensen continued, "We fully expect that the next wave of breakthroughs in cancer diagnostics will come from this group and future customers."

CTCs are cells that disseminate from primary tumors and contribute to the spread of the disease to other parts of the body.

They circulate in very low concentration in the peripheral blood and are not readily retrievable with conventional technologies.

The IsoFlux System recovers these rare tumor cells from a standard blood draw and prepares them for molecular analysis.

The platform offers improved sensitivity of CTC recovery in a low-volume format optimized for analytical platforms such as real-time quantitative PCR (qPCR), next generation sequencing (NGS), and immunofluorescence.

Initial customers have adopted the system to characterize CTCs for biomarkers including gene expression, mutations, and chromosomal aberrations.

“Our reconnaissance identified the IsoFlux instrument as a perfectly suitable technology platform for our needs in translational cancer research to analyze circulating tumor cells from patients with various cancer indications” said Dr. Norbert Kienzle at the Ingham Institute for Applied Medical Research in Sydney, Australia.

Dr. Kienzle continued, “In addition to highly sensitive recovery of CTCs and ease of system use, we need flexibility for downstream molecular and cellular analyses - the IsoFlux ticks all these boxes. Our initial hands-on experience and the constructive working relationship with Fluxion gives us confidence to go forward with our research questions on the biology and clinical utility of CTCs, ultimately aiming to improve patient outcomes in one of Sydney’s largest and fastest growing cancer populations.”

The IsoFlux System is sold globally through Fluxion in North America and a network of distributors in Europe and Asia.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Research Team from Fred Hutchinson Cancer Center Wins 2010 BioFlux Innovation Award
Group will use BioFlux System for advanced screening applications applicable to women’s reproductive health.
Saturday, September 18, 2010
Ohio State University Researchers Adopt IonFlux 16 Automated Patch Clamp System
First of kind high throughput instrument for research applications enables ion channel studies.
Monday, August 16, 2010
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Robotic Cleaning Technique Could Automate Neuroscience Research
New robotic cleaning technique allows pipettes used in patch-clamping to be re-used up to 11 or more times.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Size Matters for Particles in Bloodstream
Research uncovers more information about how particles behave in the human bloodstream.
Lab-on-a-Chip Detects Effects of Poison
A fast and efficient mixer has been developed for testing the effect of toxic substances faster by using a new lab-on-a-chip.
Analytical Science Breakthrough Could Lead To Medical Revolution
A breakthrough in analytical science s could allow pharmaceutical research to be faster and more precise.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Puttng Cells Through Their Paces
An obstacle course for human lung cells could be the answer for better testing the effectiveness of potential new drugs.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos